Loading...
•
Dec 31, 2019
Novocure Q4 2019 Earnings Report
Reported a revenue increase and a second quarter of positive net income.
Key Takeaways
Novocure reported a strong fourth quarter and full year 2019, with net revenues of $99.2 million for the quarter, representing a 42% increase compared to Q4 2018. The company achieved a net income of $4.3 million, a significant improvement from the net loss of $15.6 million in the same period of the previous year. Novocure ended the year with $326.1 million in cash, cash equivalents, and short-term investments.
Net revenues reached $99.2 million, a 42% increase compared to Q4 2018.
Achieved second quarter of positive net income with $0.04 earnings per share.
Active patients totaled 2,909 at the end of the period, representing 22% growth year-over-year.
Advanced clinical programs with four phase 3 pivotal clinical trials ongoing.
Novocure
Novocure
Novocure Revenue by Geographic Location
Revenue by Geographic Location
United States Revenue
CapyFin.comJapan Revenue
CapyFin.comGreater China Revenue
CapyFin.com Forward Guidance
Novocure anticipates several clinical milestones, including interim analyses and data releases from ongoing phase 3 pivotal trials. The company is focused on advancing its proprietary cancer therapy platform and improving patient outcomes.
Positive Outlook
- Interim analysis of phase 3 pivotal LUNAR trial in non-small cell lung cancer (H2 2020)
- Data from phase 2 pilot HEPANOVA trial in advanced liver cancer (2021)
- Data from phase 3 pivotal METIS trial in brain metastases (2021)
- Interim analysis of phase 3 pivotal PANOVA-3 trial in locally advanced pancreatic cancer (2021)
- Final data from phase 3 pivotal LUNAR trial in non-small cell lung cancer (2022)
Challenges Ahead
- Interim analysis of phase 3 pivotal INNOVATE-3 trial in recurrent ovarian cancer (2022)
- Final data from phase 3 pivotal PANOVA-3 trial in locally advanced pancreatic cancer (2022)
- Final data from phase 3 pivotal INNOVATE-3 trial in recurrent ovarian cancer (2024)
Revenue & Expenses
Visualization of income flow from segment revenue to net income